Serveur d'exploration sur les pandémies grippales

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study

Identifieur interne : 001176 ( PascalFrancis/Curation ); précédent : 001175; suivant : 001177

Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study

Auteurs : E. Cuquemelle [France] ; F. Soulis [France] ; D. Villers [France] ; F. Roche-Campo [Espagne] ; C. Ara Somohano [France] ; M. Fartoukh [France] ; A. Kouatchet [France] ; B. Mourvillier [France] ; J. Dellamonica [France] ; W. Picard [France] ; M. Schmidt [France] ; T. Boulain [France] ; C. Brun-Buisson [France]

Source :

RBID : Pascal:11-0224659

Descripteurs français

English descriptors

Abstract

Purpose: To determine whether procalcitonin (PCT) levels could help discriminate isolated viral from mixed (bacterial and viral) pneumonia in patients admitted to the intensive care unit (ICU) during the A/H1N1v2009 influenza pandemic. Methods: A retrospective observational study was performed in 23 French ICUs during the 2009 H1N1 pandemic. Levels of PCT at admission were compared between patients with confirmed influenzae A pneumonia associated or not associated with a bacterial co-infection. Results: Of 103 patients with confirmed A/H1N1 infection and not having received prior antibiotics, 48 (46.6%; 95% CI 37-56%) had a documented bacterial co-infection, mostly caused by Streptococcus pneumoniae (54%) or Staphylococcus aureus (31 %). Fifty-two patients had PCT measured on admission, including 19 (37%) having bacterial co-infection. Median (range 25-75%) values of PCT were significantly higher in patients with bacterial co-infection: 29.5 (3.9-45.3) versus 0.5 (0.12-2) μg/l (P < 0.01). For a cut-off of 0.8 μg/l or more, the sensitivity and specificity of PCT for distinguishing isolated viral from mixed pneumonia were 91 and 68%, respectively. Alveolar condensation combined with a PCT level of 0.8 μg/l or more was strongly associated with bacterial co-infection (OR 12.9, 95% CI 3.2-51.5; P < 0.001). Conclusions: PCT may help discriminate viral from mixed pneumonia during the influenza season. Levels of PCT less than 0.8 μg/l combined with clinical judgment suggest that bacterial infection is unlikely.
pA  
A01 01  1    @0 0342-4642
A02 01      @0 ICMED9
A03   1    @0 Intensive care med. : (Print)
A05       @2 37
A06       @2 5
A08 01  1  ENG  @1 Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study
A11 01  1    @1 CUQUEMELLE (E.)
A11 02  1    @1 SOULIS (F.)
A11 03  1    @1 VILLERS (D.)
A11 04  1    @1 ROCHE-CAMPO (F.)
A11 05  1    @1 ARA SOMOHANO (C.)
A11 06  1    @1 FARTOUKH (M.)
A11 07  1    @1 KOUATCHET (A.)
A11 08  1    @1 MOURVILLIER (B.)
A11 09  1    @1 DELLAMONICA (J.)
A11 10  1    @1 PICARD (W.)
A11 11  1    @1 SCHMIDT (M.)
A11 12  1    @1 BOULAIN (T.)
A11 13  1    @1 BRUN-BUISSON (C.)
A14 01      @1 Service de Reanimation médicale, Medical Intensive Care Unit, GH Henri Mondor, AP-HP, Universite Paris-Est Creteil @2 Créteil @3 FRA @Z 1 aut. @Z 13 aut.
A14 02      @1 Medical Intensive Care Unit, Centre Hospitalo-Universitaire Charles Nicolle @2 Rouen @3 FRA @Z 2 aut.
A14 03      @1 Medical Intensive Care Unit, Centre Hospitalo-Universitaire Hotel-Dieu @2 Nantes @3 FRA @Z 3 aut.
A14 04      @1 Polyvalent Intensive Care Unit, Hospital Santa Creu I Sant Pau @2 Barcelona @3 ESP @Z 4 aut.
A14 05      @1 Medical Intensive Care Unit, Centre Hospitalo-Universitaire A. Michallon @2 Grenoble @3 FRA @Z 5 aut.
A14 06      @1 Medical Intensive Care Unit, APHP, Centre Hospitalo-Universitaire Tenon, AP-HP @2 Paris @3 FRA @Z 6 aut.
A14 07      @1 Medical Intensive Care Unit, Centre Hospitalo-Universitaire @2 Angers @3 FRA @Z 7 aut.
A14 08      @1 Medical Intensive Care Unit, APHP, Centre Hospitalo-Universitaire Bichat-Claude Bernard, AP-HP @2 Paris @3 FRA @Z 8 aut.
A14 09      @1 Medical Intensive Care Unit, Centre Hospitalo-Universitaire Archet 1 @2 Nice @3 FRA @Z 9 aut.
A14 10      @1 Polyvalent Intensive Care Unit, Centre Hospitalier F. Mitterand @2 Pau @3 FRA @Z 10 aut.
A14 11      @1 Medical Intensive Care Unit, APHP, Centre Hospitalo-Universitaire Pitié-Salpétrière, Paris, AP-HP @2 Paris @3 FRA @Z 11 aut.
A14 12      @1 Medical ICU, Centre Hospitalier Regional @2 Orleans @3 FRA @Z 12 aut.
A20       @1 796-800
A21       @1 2011
A23 01      @0 ENG
A43 01      @1 INIST @2 16256 @5 354000191487590100
A44       @0 0000 @1 © 2011 INIST-CNRS. All rights reserved.
A45       @0 15 ref.
A47 01  1    @0 11-0224659
A60       @1 P
A61       @0 A
A64 01  1    @0 Intensive care medicine : (Print)
A66 01      @0 DEU
C01 01    ENG  @0 Purpose: To determine whether procalcitonin (PCT) levels could help discriminate isolated viral from mixed (bacterial and viral) pneumonia in patients admitted to the intensive care unit (ICU) during the A/H1N1v2009 influenza pandemic. Methods: A retrospective observational study was performed in 23 French ICUs during the 2009 H1N1 pandemic. Levels of PCT at admission were compared between patients with confirmed influenzae A pneumonia associated or not associated with a bacterial co-infection. Results: Of 103 patients with confirmed A/H1N1 infection and not having received prior antibiotics, 48 (46.6%; 95% CI 37-56%) had a documented bacterial co-infection, mostly caused by Streptococcus pneumoniae (54%) or Staphylococcus aureus (31 %). Fifty-two patients had PCT measured on admission, including 19 (37%) having bacterial co-infection. Median (range 25-75%) values of PCT were significantly higher in patients with bacterial co-infection: 29.5 (3.9-45.3) versus 0.5 (0.12-2) μg/l (P < 0.01). For a cut-off of 0.8 μg/l or more, the sensitivity and specificity of PCT for distinguishing isolated viral from mixed pneumonia were 91 and 68%, respectively. Alveolar condensation combined with a PCT level of 0.8 μg/l or more was strongly associated with bacterial co-infection (OR 12.9, 95% CI 3.2-51.5; P < 0.001). Conclusions: PCT may help discriminate viral from mixed pneumonia during the influenza season. Levels of PCT less than 0.8 μg/l combined with clinical judgment suggest that bacterial infection is unlikely.
C02 01  X    @0 002B27B
C02 02  X    @0 002B27B10
C03 01  X  FRE  @0 Bactériose @5 01
C03 01  X  ENG  @0 Bacteriosis @5 01
C03 01  X  SPA  @0 Bacteriosis @5 01
C03 02  X  FRE  @0 Pneumonie @5 02
C03 02  X  ENG  @0 Pneumonia @5 02
C03 02  X  SPA  @0 Neumonía @5 02
C03 03  X  FRE  @0 Procalcitonine @5 09
C03 03  X  ENG  @0 Procalcitonin @5 09
C03 03  X  SPA  @0 Procalcitonina @5 09
C03 04  X  FRE  @0 Homme @5 10
C03 04  X  ENG  @0 Human @5 10
C03 04  X  SPA  @0 Hombre @5 10
C03 05  X  FRE  @0 Grippe A @5 11
C03 05  X  ENG  @0 Influenza A @5 11
C03 05  X  SPA  @0 Gripe A @5 11
C03 06  X  FRE  @0 Réanimation @5 12
C03 06  X  ENG  @0 Resuscitation @5 12
C03 06  X  SPA  @0 Reanimación @5 12
C03 07  X  FRE  @0 Soin intensif @5 13
C03 07  X  ENG  @0 Intensive care @5 13
C03 07  X  SPA  @0 Cuidado intensivo @5 13
C07 01  X  FRE  @0 Infection
C07 01  X  ENG  @0 Infection
C07 01  X  SPA  @0 Infección
C07 02  X  FRE  @0 Virose
C07 02  X  ENG  @0 Viral disease
C07 02  X  SPA  @0 Virosis
C07 03  X  FRE  @0 Pathologie de l'appareil respiratoire @5 37
C07 03  X  ENG  @0 Respiratory disease @5 37
C07 03  X  SPA  @0 Aparato respiratorio patología @5 37
C07 04  X  FRE  @0 Pathologie des poumons @5 38
C07 04  X  ENG  @0 Lung disease @5 38
C07 04  X  SPA  @0 Pulmón patología @5 38
N21       @1 150
N44 01      @1 OTO
N82       @1 OTO

Links toward previous steps (curation, corpus...)


Links to Exploration step

Pascal:11-0224659

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study</title>
<author>
<name sortKey="Cuquemelle, E" sort="Cuquemelle, E" uniqKey="Cuquemelle E" first="E." last="Cuquemelle">E. Cuquemelle</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Service de Reanimation médicale, Medical Intensive Care Unit, GH Henri Mondor, AP-HP, Universite Paris-Est Creteil</s1>
<s2>Créteil</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Soulis, F" sort="Soulis, F" uniqKey="Soulis F" first="F." last="Soulis">F. Soulis</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Medical Intensive Care Unit, Centre Hospitalo-Universitaire Charles Nicolle</s1>
<s2>Rouen</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Villers, D" sort="Villers, D" uniqKey="Villers D" first="D." last="Villers">D. Villers</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Medical Intensive Care Unit, Centre Hospitalo-Universitaire Hotel-Dieu</s1>
<s2>Nantes</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Roche Campo, F" sort="Roche Campo, F" uniqKey="Roche Campo F" first="F." last="Roche-Campo">F. Roche-Campo</name>
<affiliation wicri:level="1">
<inist:fA14 i1="04">
<s1>Polyvalent Intensive Care Unit, Hospital Santa Creu I Sant Pau</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
</affiliation>
</author>
<author>
<name sortKey="Ara Somohano, C" sort="Ara Somohano, C" uniqKey="Ara Somohano C" first="C." last="Ara Somohano">C. Ara Somohano</name>
<affiliation wicri:level="1">
<inist:fA14 i1="05">
<s1>Medical Intensive Care Unit, Centre Hospitalo-Universitaire A. Michallon</s1>
<s2>Grenoble</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Fartoukh, M" sort="Fartoukh, M" uniqKey="Fartoukh M" first="M." last="Fartoukh">M. Fartoukh</name>
<affiliation wicri:level="1">
<inist:fA14 i1="06">
<s1>Medical Intensive Care Unit, APHP, Centre Hospitalo-Universitaire Tenon, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Kouatchet, A" sort="Kouatchet, A" uniqKey="Kouatchet A" first="A." last="Kouatchet">A. Kouatchet</name>
<affiliation wicri:level="1">
<inist:fA14 i1="07">
<s1>Medical Intensive Care Unit, Centre Hospitalo-Universitaire</s1>
<s2>Angers</s2>
<s3>FRA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Mourvillier, B" sort="Mourvillier, B" uniqKey="Mourvillier B" first="B." last="Mourvillier">B. Mourvillier</name>
<affiliation wicri:level="1">
<inist:fA14 i1="08">
<s1>Medical Intensive Care Unit, APHP, Centre Hospitalo-Universitaire Bichat-Claude Bernard, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Dellamonica, J" sort="Dellamonica, J" uniqKey="Dellamonica J" first="J." last="Dellamonica">J. Dellamonica</name>
<affiliation wicri:level="1">
<inist:fA14 i1="09">
<s1>Medical Intensive Care Unit, Centre Hospitalo-Universitaire Archet 1</s1>
<s2>Nice</s2>
<s3>FRA</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Picard, W" sort="Picard, W" uniqKey="Picard W" first="W." last="Picard">W. Picard</name>
<affiliation wicri:level="1">
<inist:fA14 i1="10">
<s1>Polyvalent Intensive Care Unit, Centre Hospitalier F. Mitterand</s1>
<s2>Pau</s2>
<s3>FRA</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Schmidt, M" sort="Schmidt, M" uniqKey="Schmidt M" first="M." last="Schmidt">M. Schmidt</name>
<affiliation wicri:level="1">
<inist:fA14 i1="11">
<s1>Medical Intensive Care Unit, APHP, Centre Hospitalo-Universitaire Pitié-Salpétrière, Paris, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Boulain, T" sort="Boulain, T" uniqKey="Boulain T" first="T." last="Boulain">T. Boulain</name>
<affiliation wicri:level="1">
<inist:fA14 i1="12">
<s1>Medical ICU, Centre Hospitalier Regional</s1>
<s2>Orleans</s2>
<s3>FRA</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Brun Buisson, C" sort="Brun Buisson, C" uniqKey="Brun Buisson C" first="C." last="Brun-Buisson">C. Brun-Buisson</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Service de Reanimation médicale, Medical Intensive Care Unit, GH Henri Mondor, AP-HP, Universite Paris-Est Creteil</s1>
<s2>Créteil</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">11-0224659</idno>
<date when="2011">2011</date>
<idno type="stanalyst">PASCAL 11-0224659 INIST</idno>
<idno type="RBID">Pascal:11-0224659</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000C78</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001176</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study</title>
<author>
<name sortKey="Cuquemelle, E" sort="Cuquemelle, E" uniqKey="Cuquemelle E" first="E." last="Cuquemelle">E. Cuquemelle</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Service de Reanimation médicale, Medical Intensive Care Unit, GH Henri Mondor, AP-HP, Universite Paris-Est Creteil</s1>
<s2>Créteil</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Soulis, F" sort="Soulis, F" uniqKey="Soulis F" first="F." last="Soulis">F. Soulis</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Medical Intensive Care Unit, Centre Hospitalo-Universitaire Charles Nicolle</s1>
<s2>Rouen</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Villers, D" sort="Villers, D" uniqKey="Villers D" first="D." last="Villers">D. Villers</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Medical Intensive Care Unit, Centre Hospitalo-Universitaire Hotel-Dieu</s1>
<s2>Nantes</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Roche Campo, F" sort="Roche Campo, F" uniqKey="Roche Campo F" first="F." last="Roche-Campo">F. Roche-Campo</name>
<affiliation wicri:level="1">
<inist:fA14 i1="04">
<s1>Polyvalent Intensive Care Unit, Hospital Santa Creu I Sant Pau</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
</affiliation>
</author>
<author>
<name sortKey="Ara Somohano, C" sort="Ara Somohano, C" uniqKey="Ara Somohano C" first="C." last="Ara Somohano">C. Ara Somohano</name>
<affiliation wicri:level="1">
<inist:fA14 i1="05">
<s1>Medical Intensive Care Unit, Centre Hospitalo-Universitaire A. Michallon</s1>
<s2>Grenoble</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Fartoukh, M" sort="Fartoukh, M" uniqKey="Fartoukh M" first="M." last="Fartoukh">M. Fartoukh</name>
<affiliation wicri:level="1">
<inist:fA14 i1="06">
<s1>Medical Intensive Care Unit, APHP, Centre Hospitalo-Universitaire Tenon, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Kouatchet, A" sort="Kouatchet, A" uniqKey="Kouatchet A" first="A." last="Kouatchet">A. Kouatchet</name>
<affiliation wicri:level="1">
<inist:fA14 i1="07">
<s1>Medical Intensive Care Unit, Centre Hospitalo-Universitaire</s1>
<s2>Angers</s2>
<s3>FRA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Mourvillier, B" sort="Mourvillier, B" uniqKey="Mourvillier B" first="B." last="Mourvillier">B. Mourvillier</name>
<affiliation wicri:level="1">
<inist:fA14 i1="08">
<s1>Medical Intensive Care Unit, APHP, Centre Hospitalo-Universitaire Bichat-Claude Bernard, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Dellamonica, J" sort="Dellamonica, J" uniqKey="Dellamonica J" first="J." last="Dellamonica">J. Dellamonica</name>
<affiliation wicri:level="1">
<inist:fA14 i1="09">
<s1>Medical Intensive Care Unit, Centre Hospitalo-Universitaire Archet 1</s1>
<s2>Nice</s2>
<s3>FRA</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Picard, W" sort="Picard, W" uniqKey="Picard W" first="W." last="Picard">W. Picard</name>
<affiliation wicri:level="1">
<inist:fA14 i1="10">
<s1>Polyvalent Intensive Care Unit, Centre Hospitalier F. Mitterand</s1>
<s2>Pau</s2>
<s3>FRA</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Schmidt, M" sort="Schmidt, M" uniqKey="Schmidt M" first="M." last="Schmidt">M. Schmidt</name>
<affiliation wicri:level="1">
<inist:fA14 i1="11">
<s1>Medical Intensive Care Unit, APHP, Centre Hospitalo-Universitaire Pitié-Salpétrière, Paris, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Boulain, T" sort="Boulain, T" uniqKey="Boulain T" first="T." last="Boulain">T. Boulain</name>
<affiliation wicri:level="1">
<inist:fA14 i1="12">
<s1>Medical ICU, Centre Hospitalier Regional</s1>
<s2>Orleans</s2>
<s3>FRA</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Brun Buisson, C" sort="Brun Buisson, C" uniqKey="Brun Buisson C" first="C." last="Brun-Buisson">C. Brun-Buisson</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Service de Reanimation médicale, Medical Intensive Care Unit, GH Henri Mondor, AP-HP, Universite Paris-Est Creteil</s1>
<s2>Créteil</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Intensive care medicine : (Print)</title>
<title level="j" type="abbreviated">Intensive care med. : (Print)</title>
<idno type="ISSN">0342-4642</idno>
<imprint>
<date when="2011">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Intensive care medicine : (Print)</title>
<title level="j" type="abbreviated">Intensive care med. : (Print)</title>
<idno type="ISSN">0342-4642</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Bacteriosis</term>
<term>Human</term>
<term>Influenza A</term>
<term>Intensive care</term>
<term>Pneumonia</term>
<term>Procalcitonin</term>
<term>Resuscitation</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Bactériose</term>
<term>Pneumonie</term>
<term>Procalcitonine</term>
<term>Homme</term>
<term>Grippe A</term>
<term>Réanimation</term>
<term>Soin intensif</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Purpose: To determine whether procalcitonin (PCT) levels could help discriminate isolated viral from mixed (bacterial and viral) pneumonia in patients admitted to the intensive care unit (ICU) during the A/H1N1v2009 influenza pandemic. Methods: A retrospective observational study was performed in 23 French ICUs during the 2009 H1N1 pandemic. Levels of PCT at admission were compared between patients with confirmed influenzae A pneumonia associated or not associated with a bacterial co-infection. Results: Of 103 patients with confirmed A/H1N1 infection and not having received prior antibiotics, 48 (46.6%; 95% CI 37-56%) had a documented bacterial co-infection, mostly caused by Streptococcus pneumoniae (54%) or Staphylococcus aureus (31 %). Fifty-two patients had PCT measured on admission, including 19 (37%) having bacterial co-infection. Median (range 25-75%) values of PCT were significantly higher in patients with bacterial co-infection: 29.5 (3.9-45.3) versus 0.5 (0.12-2) μg/l (P < 0.01). For a cut-off of 0.8 μg/l or more, the sensitivity and specificity of PCT for distinguishing isolated viral from mixed pneumonia were 91 and 68%, respectively. Alveolar condensation combined with a PCT level of 0.8 μg/l or more was strongly associated with bacterial co-infection (OR 12.9, 95% CI 3.2-51.5; P < 0.001). Conclusions: PCT may help discriminate viral from mixed pneumonia during the influenza season. Levels of PCT less than 0.8 μg/l combined with clinical judgment suggest that bacterial infection is unlikely.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0342-4642</s0>
</fA01>
<fA02 i1="01">
<s0>ICMED9</s0>
</fA02>
<fA03 i2="1">
<s0>Intensive care med. : (Print)</s0>
</fA03>
<fA05>
<s2>37</s2>
</fA05>
<fA06>
<s2>5</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>CUQUEMELLE (E.)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>SOULIS (F.)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>VILLERS (D.)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>ROCHE-CAMPO (F.)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>ARA SOMOHANO (C.)</s1>
</fA11>
<fA11 i1="06" i2="1">
<s1>FARTOUKH (M.)</s1>
</fA11>
<fA11 i1="07" i2="1">
<s1>KOUATCHET (A.)</s1>
</fA11>
<fA11 i1="08" i2="1">
<s1>MOURVILLIER (B.)</s1>
</fA11>
<fA11 i1="09" i2="1">
<s1>DELLAMONICA (J.)</s1>
</fA11>
<fA11 i1="10" i2="1">
<s1>PICARD (W.)</s1>
</fA11>
<fA11 i1="11" i2="1">
<s1>SCHMIDT (M.)</s1>
</fA11>
<fA11 i1="12" i2="1">
<s1>BOULAIN (T.)</s1>
</fA11>
<fA11 i1="13" i2="1">
<s1>BRUN-BUISSON (C.)</s1>
</fA11>
<fA14 i1="01">
<s1>Service de Reanimation médicale, Medical Intensive Care Unit, GH Henri Mondor, AP-HP, Universite Paris-Est Creteil</s1>
<s2>Créteil</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>13 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Medical Intensive Care Unit, Centre Hospitalo-Universitaire Charles Nicolle</s1>
<s2>Rouen</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03">
<s1>Medical Intensive Care Unit, Centre Hospitalo-Universitaire Hotel-Dieu</s1>
<s2>Nantes</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="04">
<s1>Polyvalent Intensive Care Unit, Hospital Santa Creu I Sant Pau</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="05">
<s1>Medical Intensive Care Unit, Centre Hospitalo-Universitaire A. Michallon</s1>
<s2>Grenoble</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="06">
<s1>Medical Intensive Care Unit, APHP, Centre Hospitalo-Universitaire Tenon, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="07">
<s1>Medical Intensive Care Unit, Centre Hospitalo-Universitaire</s1>
<s2>Angers</s2>
<s3>FRA</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="08">
<s1>Medical Intensive Care Unit, APHP, Centre Hospitalo-Universitaire Bichat-Claude Bernard, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="09">
<s1>Medical Intensive Care Unit, Centre Hospitalo-Universitaire Archet 1</s1>
<s2>Nice</s2>
<s3>FRA</s3>
<sZ>9 aut.</sZ>
</fA14>
<fA14 i1="10">
<s1>Polyvalent Intensive Care Unit, Centre Hospitalier F. Mitterand</s1>
<s2>Pau</s2>
<s3>FRA</s3>
<sZ>10 aut.</sZ>
</fA14>
<fA14 i1="11">
<s1>Medical Intensive Care Unit, APHP, Centre Hospitalo-Universitaire Pitié-Salpétrière, Paris, AP-HP</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>11 aut.</sZ>
</fA14>
<fA14 i1="12">
<s1>Medical ICU, Centre Hospitalier Regional</s1>
<s2>Orleans</s2>
<s3>FRA</s3>
<sZ>12 aut.</sZ>
</fA14>
<fA20>
<s1>796-800</s1>
</fA20>
<fA21>
<s1>2011</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>16256</s2>
<s5>354000191487590100</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2011 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>15 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>11-0224659</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Intensive care medicine : (Print)</s0>
</fA64>
<fA66 i1="01">
<s0>DEU</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>Purpose: To determine whether procalcitonin (PCT) levels could help discriminate isolated viral from mixed (bacterial and viral) pneumonia in patients admitted to the intensive care unit (ICU) during the A/H1N1v2009 influenza pandemic. Methods: A retrospective observational study was performed in 23 French ICUs during the 2009 H1N1 pandemic. Levels of PCT at admission were compared between patients with confirmed influenzae A pneumonia associated or not associated with a bacterial co-infection. Results: Of 103 patients with confirmed A/H1N1 infection and not having received prior antibiotics, 48 (46.6%; 95% CI 37-56%) had a documented bacterial co-infection, mostly caused by Streptococcus pneumoniae (54%) or Staphylococcus aureus (31 %). Fifty-two patients had PCT measured on admission, including 19 (37%) having bacterial co-infection. Median (range 25-75%) values of PCT were significantly higher in patients with bacterial co-infection: 29.5 (3.9-45.3) versus 0.5 (0.12-2) μg/l (P < 0.01). For a cut-off of 0.8 μg/l or more, the sensitivity and specificity of PCT for distinguishing isolated viral from mixed pneumonia were 91 and 68%, respectively. Alveolar condensation combined with a PCT level of 0.8 μg/l or more was strongly associated with bacterial co-infection (OR 12.9, 95% CI 3.2-51.5; P < 0.001). Conclusions: PCT may help discriminate viral from mixed pneumonia during the influenza season. Levels of PCT less than 0.8 μg/l combined with clinical judgment suggest that bacterial infection is unlikely.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B27B</s0>
</fC02>
<fC02 i1="02" i2="X">
<s0>002B27B10</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Bactériose</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Bacteriosis</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Bacteriosis</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Pneumonie</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Pneumonia</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Neumonía</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Procalcitonine</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Procalcitonin</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Procalcitonina</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Homme</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Human</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Hombre</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Grippe A</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Influenza A</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Gripe A</s0>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Réanimation</s0>
<s5>12</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Resuscitation</s0>
<s5>12</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Reanimación</s0>
<s5>12</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Soin intensif</s0>
<s5>13</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Intensive care</s0>
<s5>13</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Cuidado intensivo</s0>
<s5>13</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Infection</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Infection</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Infección</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Virose</s0>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Viral disease</s0>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Virosis</s0>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Pathologie de l'appareil respiratoire</s0>
<s5>37</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Respiratory disease</s0>
<s5>37</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Aparato respiratorio patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Pathologie des poumons</s0>
<s5>38</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Lung disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Pulmón patología</s0>
<s5>38</s5>
</fC07>
<fN21>
<s1>150</s1>
</fN21>
<fN44 i1="01">
<s1>OTO</s1>
</fN44>
<fN82>
<s1>OTO</s1>
</fN82>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/PascalFrancis/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001176 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 001176 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:11-0224659
   |texte=   Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021